Categories AlphaGraphs, Earnings, Health Care

Infographic: Key numbers from Johnson & Johnson (JNJ) Q2 2020 earnings announcement

Johnson & Johnson (NYSE: JNJ) reported second quarter 2020 earnings results today.

Reported sales decreased 10.8% to $18.3 billion. GAAP earnings fell 35% to $3.6 billion, or $1.36 per share. Adjusted EPS dropped 35% to $1.67.

The company raised its guidance for the full year of 2020. Reported sales are estimated to come in the range of $79.9-81.4 billion and adjusted EPS is expected to be $7.75-7.95.

Check this space for the transcript of Johnson & Johnson Q2 2020 earnings conference call

Past Performance

Also Read:  ERYTECH Pharma S.A. (ERYP) Q2 2020 Earnings Call Transcript

Most Popular

What awaits Herman Miller (MLHR) beyond the home-office rush?

Herman Miller Inc. (NASDAQ: MLHR) is one of the few Wall Street firms that managed to take advantage of the opportunities created by the pandemic, after being hit by the

Cognizant’s (CTSH) buying spree in 2020

Cognizant Technology Solutions (NASDAQ: CTSH) has been on a buying spree in 2020. The portfolio of the acquisitions that Cognizant made this year is expected to help the company in

Major earnings conferences to watch for the week of Sept. 21

After registering a slow recovery in the first half of the week, the markets pared these gains on Thursday and Friday. The weakness witnessed in the latter half of the

Top